Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001716110-17-000002
Filing Date
2017-09-11
Accepted
2017-09-11 11:47:28
Documents
1
Effectiveness Date
2017-09-11
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5740
  Complete submission text file 0001716110-17-000002.txt   6825
Mailing Address 708 QUINCE ORCHARD ROAD SUITE 250-C GAITHERSBURG MD 20878
Business Address 708 QUINCE ORCHARD ROAD SUITE 250-C GAITHERSBURG MD 20878 301-365-5385
Antidote Therapeutics, Inc. (Filer) CIK: 0001716110 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-294374 | Film No.: 171078450